Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations
Authors:
- Paolo CuratoloPCPaolo Curatolo
- Sergiusz JóźwiakSergiusz Jóźwiak
- Rima NabboutRNRima Nabbout
- 1 November 2012
- journal article
- review article
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 16 (6) , 582-586
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) PathwayPLOS ONE, 2012
- Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complexEuropean Journal of Paediatric Neurology, 2011
- The natural history of epilepsy in tuberous sclerosis complexEpilepsia, 2010
- Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complexNeurology, 2010
- Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsiesEpilepsia, 2009
- Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasiaDisease Models & Mechanisms, 2009
- Recent advances in neurobiology of Tuberous Sclerosis ComplexBrain and Development, 2009
- Rapamycin Reduces Seizure Frequency in Tuberous Sclerosis ComplexJournal of Child Neurology, 2009
- Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosisNature Medicine, 2008
- Tuberous sclerosisEuropean Journal of Human Genetics, 2006